etofylline clofibrate has been researched along with Hyperlipidemias in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scherhag, R | 1 |
| Chibanguza, G; Metz, G; Sterner, W | 1 |
| Metz, G; Specker, M; Ziegler, WJ | 1 |
| Föger, B; Hopferwieser, T; Lechleitner, M; Menzel, HJ; Patsch, JR; Pfeiffer, KP; Ritsch, A; Tröbinger, G; Utermann, G | 1 |
4 other study(ies) available for etofylline clofibrate and Hyperlipidemias
| Article | Year |
|---|---|
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Topics: Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Time Factors; Uric Acid | 1983 |
[Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Topics: Animals; Body Weight; Clofibrate; Diet; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rats | 1980 |
[Clinical effects and tolerance of etofylline clofibrate].
Topics: Clofibrate; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents | 1980 |
Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
Topics: Carrier Proteins; Cholesterol Ester Transfer Proteins; Chylomicrons; Clofibrate; Eating; Female; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Transaminases; Triglycerides; Vitamin A | 1995 |